Yuan Xu - Net Worth and Insider Trading

Yuan Xu Net Worth

The estimated net worth of Yuan Xu is at least $27,481 dollars as of 2024-11-29. Yuan Xu is the Director of Fate Therapeutics Inc and owns about 8,669 shares of Fate Therapeutics Inc (FATE) stock worth over $27,481. Details can be seen in Yuan Xu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yuan Xu has not made any transactions after 2024-08-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Yuan Xu

To

Yuan Xu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yuan Xu owns 3 companies in total, including Fate Therapeutics Inc (FATE) , Akero Therapeutics Inc (AKRO) , and Xilio Therapeutics Inc (XLO) .

Click here to see the complete history of Yuan Xu’s form 4 insider trades.

Insider Ownership Summary of Yuan Xu

Ticker Comapny Transaction Date Type of Owner
FATE Fate Therapeutics Inc 2024-08-06 director
AKRO Akero Therapeutics Inc 2022-06-02 director
XLO Xilio Therapeutics Inc 2022-01-04 director

Yuan Xu Latest Holdings Summary

Yuan Xu currently owns a total of 1 stock. Yuan Xu owns 8,669 shares of Fate Therapeutics Inc (FATE) as of August 6, 2024, with a value of $27,481.

Latest Holdings of Yuan Xu

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FATE Fate Therapeutics Inc 2024-08-06 8,669 3.17 27,481

Holding Weightings of Yuan Xu


Yuan Xu Form 4 Trading Tracker

According to the SEC Form 4 filings, Yuan Xu has made a total of 3 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 633 shares on August 6, 2024, which brought Yuan Xu around $2,678.

Insider Trading History of Yuan Xu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yuan Xu Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Yuan Xu Ownership Network

Ownership Network List of Yuan Xu

No Data

Ownership Network Relation of Yuan Xu

Insider Network Chart

Yuan Xu Owned Company Details

What does Fate Therapeutics Inc do?

Who are the key executives at Fate Therapeutics Inc?

Yuan Xu is the director of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .

Fate Therapeutics Inc (FATE) Insider Trades Summary

Over the past 18 months, Yuan Xu made 3 insider transaction in Fate Therapeutics Inc (FATE) with a net sale of 4,725. Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 18,777 shares made by Dulac Edward J Iii , a net sale of 35,237 shares made by Cindy Tahl , and a net purchase of 44,630 shares made by Redmile Group, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 88,255 shares of Fate Therapeutics Inc (FATE) were sold and 44,630 shares were bought by its insiders, resulting in a net sale of 43,625 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fate Therapeutics Inc Insider Transactions

No Available Data

Yuan Xu Mailing Address

Above is the net worth, insider trading, and ownership report for Yuan Xu. You might contact Yuan Xu via mailing address: C/o Akero Therapeutics, Inc., 601 Gateway Boulevard, Suite 350, South San Francisco Ca 94080.

Discussions on Yuan Xu

No discussions yet.